Viewing Study NCT06525766


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-28 @ 8:47 PM
Study NCT ID: NCT06525766
Status: RECRUITING
Last Update Posted: 2025-10-03
First Post: 2024-07-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Estrogen-receptor-positive Breast Cancer View
None Metastatic HER2-Negative Breast Carcinoma View
None Metastatic Breast Cancer View
Keywords: